These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 407240)

  • 1. Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.
    Ishibashi M; Yamaji T; Kosaka K
    J Clin Endocrinol Metab; 1977 Aug; 45(2):275-9. PubMed ID: 407240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of growth hormone and prolactin secretion by luteinizing hormone-releasing hormone and its blockade by bromoergocriptine in acromegalic patients.
    Ishibashi M; Yamaji T; Kosaka K
    J Clin Endocrinol Metab; 1978 Aug; 47(2):418-21. PubMed ID: 400720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lisuride hydrogen maleate: evidence for a long lasting dopaminergic activity in humans.
    Liuzzi A; Chiodini PG; Oppizzi G; Botalla L; Verde G; De Stefano L; Colussi G; Gräf KJ; Horowski R
    J Clin Endocrinol Metab; 1978 Feb; 46(2):196-202. PubMed ID: 108287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients.
    De Marinis L; Mancini A; Zuppi P; Fiumara C; Conte G; Sammartano L; Fabrizi ML; Valle D
    Exp Clin Endocrinol Diabetes; 1996; 104(1):67-71. PubMed ID: 8750573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the dopamine agonist, lergotrile mesylate, on circulating anterior pituitary hormones in man.
    Thorner MO; Ryan SM; Wass JA; Jones A; Bouloux P; Williams S; Besser GM
    J Clin Endocrinol Metab; 1978 Aug; 47(2):372-8. PubMed ID: 45463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone response to thyrotropin-releasing hormone in acromegalic patients: reproducibility and dose-response study.
    Villabona CM; Soler J; Virgili N; Gómez JM; Montaña E; Navarro MA
    Horm Res; 1992; 37(1-2):14-17. PubMed ID: 1398470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
    Marek J; Límanová Z; Srámková J
    Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects.
    Camanni F; Massara F; Belforte L; Rosatello A; Molinatti GM
    J Clin Endocrinol Metab; 1977 Mar; 44(3):465-73. PubMed ID: 838847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with 2-Br-alpha-ergocryptine in acromegaly.
    Belforte L; Camanni F; Chiodini PG; Liuzzi A; Massara F; Molinatti GM; Müller EE; Silvestrini F
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):235-48. PubMed ID: 405832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute infusion of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in acromegalic patients.
    Díez JJ; Iglesias P; Sastre J; Gómez-Pan A
    Eur J Endocrinol; 2000 Aug; 143(2):203-11. PubMed ID: 10913939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anomalous growth hormone responses to thyrotropin-releasing hormone and glucose in cirrhotic patients: the effect of metergoline.
    Salerno F; Cocchi D; Frigerio C; Colombo AM; Müller EE
    J Clin Endocrinol Metab; 1980 Sep; 51(3):641-6. PubMed ID: 6773980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulpiride and thyrotrophin releasing hormone loading test in patients with acromegaly.
    Zséli J; Földes J; Holló I; Kollin E; Horváth C; Gács G; Borvendég J
    Acta Med Acad Sci Hung; 1980; 37(4):357-64. PubMed ID: 6785978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Response of growth hormone to sandostatin and bromocriptine and prognostic value of prolactin levels in serum and thyroliberin test in patients with active acromegaly].
    Gasińska T; Nowak S
    Endokrynol Pol; 1993; 44(4):455-65. PubMed ID: 8055814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine.
    Chiodini PG; Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG
    J Clin Endocrinol Metab; 1985 Jan; 60(1):48-52. PubMed ID: 3917270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.